SXI Life Sciences
6.950,72
PKT
-25,18
PKT
-0,36
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Roche Outperform | Bernstein Research | |
23.03.21 | Roche Neutral | UBS AG | |
23.03.21 | Roche Hold | Deutsche Bank AG | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Roche overweight | Barclays Capital | |
22.03.21 | Novartis market-perform | Bernstein Research | |
22.03.21 | Roche Neutral | UBS AG | |
22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
16.03.21 | Roche Hold | Jefferies & Company Inc. | |
15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.03.21 | Roche Neutral | UBS AG | |
10.03.21 | Novartis buy | Deutsche Bank AG | |
09.03.21 | Roche buy | Citigroup Corp. | |
09.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
09.03.21 | Novartis buy | Jefferies & Company Inc. | |
08.03.21 | Roche Neutral | UBS AG | |
24.02.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.02.21 | Novartis buy | UBS AG | |
18.02.21 | Novartis buy | Deutsche Bank AG | |
17.02.21 | Roche Neutral | UBS AG | |
16.02.21 | Novartis buy | Deutsche Bank AG | |
15.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
15.02.21 | Roche Hold | Deutsche Bank AG | |
12.02.21 | Roche Outperform | Bernstein Research | |
11.02.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
10.02.21 | Novartis buy | Deutsche Bank AG | |
10.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
09.02.21 | Novartis buy | Deutsche Bank AG | |
05.02.21 | Roche Hold | Deutsche Bank AG | |
05.02.21 | Roche Neutral | Credit Suisse Group | |
04.02.21 | Roche Outperform | Bernstein Research | |
04.02.21 | Roche buy | Jefferies & Company Inc. | |
04.02.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. |